Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor XIII: enzymatic and clinical aspects.

H E Karges1, R Clemens

  • 1Research Laboratories of Behringwerke AG, Marburg, W. Germany.

Behring Institute Mitteilungen
|April 1, 1988
PubMed
Summary

Clotting Factor XIII (FXIII) is a transglutaminase, not a true clotting factor. FXIII crosslinks proteins, reduces vascular permeability, and aids wound healing, with demonstrated clinical effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of transportation and lairage on faecal shedding and carcass contamination with Escherichia coli O157 and O26 in very young calves in New Zealand.

Epidemiology and infection·2018
Same author

Cognitive function in patients with peripheral artery disease: a prospective single-center cohort study.

International angiology : a journal of the International Union of Angiology·2014
Same author

The influence of abdominal pressure on lower extremity venous pressure and hemodynamics: a human in-vivo model simulating the effect of abdominal obesity.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2011
Same author

Condom-use skills checklist: a proxy for assessing condom-use knowledge and skills when direct observation is not possible.

Journal of health, population, and nutrition·2009
Same author

Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.

Vaccine·2006
Same author

Evaluation of molecular methods to determine enterotoxigenic status and molecular genotype of bovine, ovine, human and food isolates of Staphylococcus aureus.

International journal of food microbiology·2005

Area of Science:

  • Biochemistry
  • Cell Biology
  • Clinical Medicine

Background:

  • Clotting Factor XIII (FXIII) plays a multifaceted role beyond traditional coagulation.
  • Its enzymatic activity involves protein crosslinking via a transamidase reaction.

Purpose of the Study:

  • To elucidate the broader biological functions of FXIII.
  • To review clinical evidence supporting FXIII's therapeutic potential.

Main Methods:

  • Review of existing knowledge on FXIII.
  • Analysis of cell culture studies, animal experiments, and clinical data.

Main Results:

  • FXIII functions as a transglutaminase, crosslinking proteins.
  • FXIII reduces microvasculature permeability and stimulates connective tissue cells.
  • Clinical effects observed in scleroderma, subarachnoid hemorrhage, inflammatory bowel diseases, and wound healing.

Conclusions:

  • FXIII's biological functions extend to tissue repair and stabilization.
  • FXIII demonstrates therapeutic promise in various clinical conditions.

Related Experiment Videos